Keith Higgins - Concepedia

Author

Keith Higgins

Global Solutions for Infectious Diseases

Also Known As

K HIGGINS, K Higgins, K W Higgins, K. W. Higgins, KEITH W. HIGGINS, Keith Higgins, Keith W. Higgins

Publications

676

Citations

H-Index

Concepts

All Affiliations

Global Solutions for Infectious Diseases Novartis (Switzerland)Oregon Health & Science University New York University Icahn School of Medicine at Mount Sinai

About

Keith Higgins is an author at Global Solutions for Infectious Diseases specializing in immunology, medicine, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	567
2	Immunology	9	9	567
3	Allergy	3	3	199
4	Engineering	1	1	98
5	Molecular Biology	1	1	137

Keith Higgins

Publications

670

Citations

H-Index

Page 1

	Year	Citations
Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons Nancy L. Haigwood, Peter L. Nara, Ellena Brooks, Journal of Virology Conserved EpitopesHuman RetrovirusImmunologyAntiviral ResponseMolecular Biology	1992	137
Simultaneous determination of total IgE and allergen-specific IgE in serum by the MAST chemiluminescent assay system. Caroline Brown, Keith Higgins, Kelly A. Frazer, Clinical Chemistry EngineeringCla SystemImmunologyAllergenAllergen-specific Ige	1985	98
Importance of Hypervariable Regions of HIV-1 gp120 in the Generation of Virus Neutralizing Antibodies Nancy L. Haigwood, Jeffrey R. Shuster, Gregory K. Moore, AIDS Research and Human Retroviruses Synthetic VirologyImmunologyPathologyVirus Neutralizing AntibodiesViral Structural Protein	1990	94
Recombinant polypeptide from the endonuclease region of the acquired immune deficiency syndrome retrovirus polymerase (pol) gene detects serum antibodies in most infected individuals Kathelyn S. Steimer, Keith Higgins, Maureen A. Powers, Journal of Virology Viral ReplicationImmunologyMost Infected IndividualsHuman RetrovirusRecombinant Polypeptide	1986	71
Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge Cyril Empig, Julie Kenner, Bryan Youree, Vaccine VaccinationVaccinologyPathogenic Orthopoxvirus ChallengeMucosal VaccinationVaccine Development	2005	57
Resistance of chimpanzees immunized with recombinant gp120SF2 to challenge by HIV-1SF2 Zahwa El-Amad, KRISHNA K. MURTHY, Keith Higgins, AIDS	1995	49
Microparticles in MF59, a potent adjuvant combination for a recombinant protein vaccine against HIV-1 Derek T. O’Hagan, Mildred Ugozzoli, John D. Barackman, Vaccine VaccinationPotent Adjuvant CombinationImmunologyTherapeutic VaccineRecombinant Protein Vaccine	2000	46
Sequential immunizations with rgp120s from independent isolates of human immunodeficiency virus type 1 induce the preferential expansion of broadly crossreactive B cells. Dennis M. Klinman, Keith Higgins, Jacqueline Conover The Journal of Experimental Medicine Adaptive Immune SystemHumoral ResponseImmunologyEnvelope GlycoproteinImmunotherapy	1991	30
Functional Antibody Response Against V1V2 and V3 of HIV gp120 in the VAX003 and VAX004 Vaccine Trials Preetha Balasubramanian, Constance Williams, Mariya B. Shapiro, Scientific Reports	2018	30
Differential induction of anti-V3 crown antibodies with cradle- and ladle-binding modes in response to HIV-1 envelope vaccination Preetha Balasubramanian, Rajnish Kumar, Constance Williams, Vaccine VaccinationHiv-1 Envelope VaccinationHuman RetrovirusImmunologyAntiviral Response	2017	18

Page 1